<DOC>
	<DOCNO>NCT01070615</DOCNO>
	<brief_summary>Objectives : Evaluation clinical long-term safety , tolerability , patient satisfaction , pharmacokinetics pattern use oral prucalopride tablet give dose 4 mg daily patient chronic constipation</brief_summary>
	<brief_title>Study Evaluate Long-Term Tolerability Safety Oral Prucalopride Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Male nonpregnant , nonbreastfeeding female outpatient least 18 year age 2 . Patient complete entire treatment period PRUINT6 study PRUINT12 study . 1 . Patients impaired renal function 2 . Patients clinically significant abnormality haematology , urinalysis , blood chemistry . 3 . Females childbearing potential without adequate contraceptive protection study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>